IMMUNPHETONYPING PANEL REPOSITIONING: NEW WAYS TO ANALYZE ACUTE MYELOID LEUKEMIA BIOMARKERS AND THEIR RELEVANCE
One of the greatest obstacles in the treatment of Acute Myeloid Leukemia (AML) is relapse, occurring in 40-50% of younger patients and most elderly patients. The Leukemia Stem Cells (LSCs) model suggests that only a small population of cancer cells is responsible for treatment resistance and recurre...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923004984 |